• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年抑郁症的快速反应:一项结合睡眠剥夺与帕罗西汀的初步研究

Accelerating response in geriatric depression: a pilot study combining sleep deprivation and paroxetine.

作者信息

Bump G M, Reynolds C F, Smith G, Pollock B G, Dew M A, Mazumdar S, Geary M, Houck P R, Kupfer D J

机构信息

Mental Health Clinical Research Center for the Study of Late-Life Mood Disorders, University of Pittsburgh, PA 15213, USA.

出版信息

Depress Anxiety. 1997;6(3):113-8.

PMID:9442985
Abstract

Elderly depressed patients often require an average of 12 weeks of pharmacotherapy before attaining remission. The delay between treatment initiation and remission may decrease compliance and prolongs suffering; hence, interventions that decrease the time to onset of antidepressant activity are needed. Our objective was to evaluate, in an open trial, the use of one night of total sleep deprivation combined with paroxetine to accelerate antidepressant response in elderly patients. Thirteen elderly patients with major depression were sleep-deprived for one night and started paroxetine on the night of recovery sleep. Patients were followed for twelve weeks, and clinical improvement was rated using the 17-item Hamilton Depression Rating Scale and a version of the Hamilton modified for sleep deprivation studies. 8/13 (62%) patients experienced significant improvement of depressive symptoms by 2 weeks. Within 12 weeks 11/13 (85%) patients responded to the combination of sleep deprivation and paroxetine. Median response time was 2 weeks. Clinical response at 12 weeks was correlated with changes in Sleep Deprivation Depression Rating Scale Scores between baseline and recovery sleep. In an open trial, the combined use of total sleep deprivation and paroxetine appears to be an effective method for speeding the onset of clinical antidepressant activity in geriatric depression and for improving early recognition of non-response.

摘要

老年抑郁症患者通常平均需要12周的药物治疗才能达到症状缓解。从开始治疗到症状缓解之间的延迟可能会降低依从性并延长痛苦;因此,需要采取干预措施来缩短抗抑郁活性起效的时间。我们的目的是在一项开放性试验中评估,使用一晚的完全睡眠剥夺联合帕罗西汀,以加速老年患者的抗抑郁反应。13名患有重度抑郁症的老年患者被剥夺睡眠一晚,并在恢复睡眠的当晚开始服用帕罗西汀。对患者进行了为期12周的随访,并使用17项汉密尔顿抑郁量表以及为睡眠剥夺研究修改的汉密尔顿量表版本对临床改善情况进行评分。8/13(62%)的患者在2周时抑郁症状有显著改善。在12周内,11/13(85%)的患者对睡眠剥夺和帕罗西汀的联合治疗有反应。中位反应时间为2周。12周时的临床反应与基线睡眠和恢复睡眠之间睡眠剥夺抑郁量表评分的变化相关。在一项开放性试验中,完全睡眠剥夺与帕罗西汀联合使用似乎是加速老年抑郁症临床抗抑郁活性起效以及改善对无反应的早期识别的有效方法。

相似文献

1
Accelerating response in geriatric depression: a pilot study combining sleep deprivation and paroxetine.老年抑郁症的快速反应:一项结合睡眠剥夺与帕罗西汀的初步研究
Depress Anxiety. 1997;6(3):113-8.
2
Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression.老年抑郁症患者全睡眠剥夺与抗抑郁治疗联合应用时的脑葡萄糖代谢反应
Am J Psychiatry. 1999 May;156(5):683-9. doi: 10.1176/ajp.156.5.683.
3
[Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder].[与舍曲林单一疗法相比,舍曲林联合睡眠剥夺和光照疗法治疗重度抑郁症的联合疗法]
Turk Psikiyatri Derg. 2005 Winter;16(4):245-51.
4
Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.米氮平与帕罗西汀治疗重度抑郁症:从治疗开始时单药治疗与联合治疗的比较
Eur Neuropsychopharmacol. 2009 Jul;19(7):457-65. doi: 10.1016/j.euroneuro.2009.01.015. Epub 2009 Apr 2.
5
Accelerating symptom-reduction in late-life depression: a double-blind, randomized, placebo-controlled trial of sleep deprivation.加速老年抑郁症症状缓解:一项睡眠剥夺的双盲、随机、安慰剂对照试验
Am J Geriatr Psychiatry. 2005 May;13(5):353-8. doi: 10.1176/appi.ajgp.13.5.353.
6
Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder.部分睡眠剥夺疗法联合舍曲林能更快速地改善重度抑郁症患者的生活质量项目。
J Affect Disord. 2005 Sep;88(1):75-8. doi: 10.1016/j.jad.2005.04.008.
7
Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.在使用帕罗西汀而非奈法唑酮对抑郁症进行药物治疗期间,睡眠慢波活动的重新分布情况。
J Sleep Res. 2009 Sep;18(3):342-8. doi: 10.1111/j.1365-2869.2008.00724.x. Epub 2009 Jun 22.
8
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.度洛西汀用于重度抑郁症的急性和长期治疗:一项安慰剂及帕罗西汀对照试验
Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70. doi: 10.1016/j.euroneuro.2004.01.002.
9
Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression.睡眠剥夺疗法的快速抗抑郁作用与重度抑郁症患者血清脑源性神经营养因子(BDNF)的变化相关。
Brain Res Bull. 2009 Sep 28;80(3):158-62. doi: 10.1016/j.brainresbull.2009.06.016. Epub 2009 Jul 1.
10
Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study.帕罗西汀治疗血液系统恶性肿瘤伴发抑郁症患者:一项开放标签研究。
Hum Psychopharmacol. 2004 Jan;19(1):25-9. doi: 10.1002/hup.541.

引用本文的文献

1
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder.在患有重度抑郁症的患者中,中枢神经系统渗透和选择性嘌呤 P2X7 受体拮抗剂 JNJ-54175446 的特征。
Transl Psychiatry. 2023 Jul 24;13(1):266. doi: 10.1038/s41398-023-02557-5.
2
Treatment fidelity evidence for BE-ACTIV - a behavioral intervention for depression in nursing homes.治疗一致性证据 BE-ACTIV- 一种用于养老院抑郁症的行为干预。
Aging Ment Health. 2019 Sep;23(9):1192-1202. doi: 10.1080/13607863.2018.1484888. Epub 2018 Dec 6.
3
Chronobiological Therapy for Mood Disorders.
情绪障碍的时间生物学疗法
Curr Psychiatry Rep. 2015 Dec;17(12):95. doi: 10.1007/s11920-015-0633-6.
4
Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression: a randomized, placebo-controlled study.老年抑郁症患者中联合完全睡眠剥夺与抗抑郁治疗的脑葡萄糖代谢反应:一项随机、安慰剂对照研究
Psychiatry Res. 2009 Jan 30;171(1):1-9. doi: 10.1016/j.pscychresns.2008.05.001. Epub 2008 Dec 16.
5
Paroxetine: a review.帕罗西汀:综述
CNS Drug Rev. 2001 Spring;7(1):25-47. doi: 10.1111/j.1527-3458.2001.tb00189.x.